HERZUMA subst sèche 150 mg flac

7680678920027 CH-67892 L01FD01 07.16.1.

Reimbursement limitations:

HERZUPERJ.01

HERZUMA en association avec le pertuzumab (PERJETA) comme traitement adjuvant du cancer du sein
Les …

HERZUMA subst sèche 150 mg flac
HERZUMA subst sèche 150 mg flac
HERZUMA subst sèche 150 mg flac
1 / 3
google

Details

Product number
6789202
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: trastuzumabum 150 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro.

Articles (1)

Herzuma 150 mg, poudre pour solution à diluer pour perfusion
Puder
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/06/2022
Professional SmPC
Français
14/06/2022
Professional SmPC
Italien
14/06/2022

Detailed composition

Substance Quantity Type Category
PRC
150.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 513.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2021

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
67892
Drug name
Herzuma, poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
L01FD01
Authorization status
Z
Dispensation category
A
First authorization
13/07/2021
Authorization expiration date
13/07/2026
IT number
07.16.1.
Domain
Human medicine

Packaging details

Description (FR)
HERZUMA subst sèche 150 mg flac
Description (DE)
HERZUMA Trockensub 150 mg Durchstf
Market launch
13/07/2021
Narcotic (BTM)
No

Other packaging sizes

HERZUMA subst sèche 440 mg c solv flac
1 DUR
View